When you get a doctorate in small molecule chemistry, your career traditionally goes in two directions: developing new drugs for big pharma or training new chemists. Chris opted for a third, uncharted direction: unlocking the true potential of cannabis to deliver brand-new highs and therapeutic solutions with targeted effects.
LabAroma Podcast with Chris Emerson, PhD
Check out this intelligent and insightful conversation with Chris Emerson PhD and LabAroma founder and clinical aromatherapist Colleen Quinn as they discuss how science is unlocking the world of emergent cannabinoids and the future of effects-based cannabis.
